Ovid Therapeutics Inc.
USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY

Last updated:

Abstract:

Methods and compositions for treating narcolepsy are provided which include administering gaboxadol or a pharmaceutically acceptable salt thereof to a patient diagnosed with narcolepsy. Also provided are methods and compositions for treating narcolepsy which include administering to a patient in need thereof gaboxadol or a pharmaceutically acceptable salt thereof, in combination with one or more of a CNS stimulant, a eugeroic agent, an antidepressant or a GABA.sub.B receptor agonist.

Status:
Application
Type:

Utility

Filling date:

25 Mar 2020

Issue date:

16 Jul 2020